Scientists test Lab-Grown eye cells to fight blinding disease
NCT ID NCT04627428
Summary
This early-stage study is testing whether transplanting lab-grown retinal cells into the eye is safe and tolerable for people with dry age-related macular degeneration (AMD). Researchers will enroll 18 adults over age 55 to receive cells derived from donor eye tissue. The main goal is to check for safety issues, but they will also monitor if the treatment helps preserve or improve vision over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Retina Vitreous Associates Medical Group
RECRUITINGBeverly Hills, California, 90211, United States
Contact
-
Spencer Center for Vision Research
RECRUITINGPalo Alto, California, 94303, United States
Contact
-
University of Michigan Kellogg Eye Center
RECRUITINGAnn Arbor, Michigan, 48105, United States
Contact
Conditions
Explore the condition pages connected to this study.